Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism

Journal of Neuroscience Research

Volumn 48, Issue 1, 1997, Pages 1-17

  Longo, Frank M ^a   Manthorpe, Marston ^b,c   Xie, Youmei M ^a   Varon, Silvio ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VICAL INC   (United States)

Author keywords

nerve growth factor; neurotrophic factors; neurotrophins; NGF; p75; peptide fragments; synthetic peptides; TrK

Indexed keywords

NERVE GROWTH FACTOR; PEPTIDE DERIVATIVE;

ANIMAL CELL; ARTICLE; BIOASSAY; CELL DEATH; CELL SURVIVAL; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NERVE CELL NECROSIS; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; BIOLOGICAL ASSAY; CELL DEATH; CELL SURVIVAL; CHICK EMBRYO; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIMERIZATION; DISULFIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; NEURITES; NEURONS; NEUROPEPTIDES; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; SUBCELLULAR FRACTIONS;

EID: 0030972560     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19970401)48:1<1::AID-JNR1>3.0.CO;2-K     Document Type: Article

References (56)

1. Ariens EJ, Beld AJ, Rodrigues de Miranda JF, Simonis AM (1979): The pharmacon-receptor-effector concept. A basis for understanding the transmission of information in biological systems. In O'Brien RD (ed): "The Receptors. A Comprehensive Treatise." New York: Cornell University, pp 33-90.
2. Baird A, Schubert D, Ling N, Guillemin R (1988): Receptor- and heparin-binding domains of basic fibroblast growth factor. Proc Natl Acad Sci USA 85:2324-2328.
3. Barker PA, Shooter EM (1994): Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells. Neuron 13:203-215.
4. Barren GL, Bartlett PF (1994): The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc Natl Acad Sci USA 91:6501-6505.
5. Barren GL, Georgiou A (1996): The low-affinity nerve growth factor receptor p75(NGFR) mediates death of PC12 cells after nerve growth factor withdrawal. J Neurosci Res 45:117-128.
6. Beutler B, van Huffel C (1994): Unraveling function in the INF ligand and receptor families. Science 264:667-668.
7. NTR: A receptor after all. Science 272:506.
8. Bradshaw RA, Blundell TL, Lapatlo R, McDonald NQ, Murray-Rust J (1993): Nerve growth factor revisited. TIBS 18:48-52.
9. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bohm-Matthaei R, Baeuerle PA, Barde Y-A (1996): Selective activation of NF-kB by nerve growth factor through the neurotrophin receptor p75. Science 272:542-545.
10. Chao MV, Hempstead BL (1995): p75 and Trk: A two-receptor system. TINS 18:321-326.
11. Chau RMW, Skaper SD, Varon S (1988): Peroxidative block of glucose utilization and survival in CNS neuronal cultures. Neurochem Res 13:611-616.
12. Cuello AC, Garofalo L, Kenigsberg RL, Maysinger D (1989): Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Proc Natl Acad Sci USA 86:2056-2060.
13. Ferrari G, Anderson BL, Stephens RM, Kaplan DR, Greene LA (1995): Prevention of apoptotic neuronal death by GM1 gangliosidc. J Biol Chem 270:3074-3080.
14. Grant GA (1992): "Synthetic Peptides: A User's Guide." New York: W. H. Freeman and Co.
15. Greene LA, Kaplan DR (1995): Early events in neurotrophin signaling via Trk and p75 receptors. Curr Op Neurol 5:579-587.
16. Hruby VJ, A1-Obeidi F, Kazmierski W (1990): Emerging approaches in the molecular design of receptor-selective peptide ligands: Conformational, topographical and dynamic considerations. Biochem J 268:249-262.
17. Huber LJ, Chao MV (1995): A potential interaction of p75 and trkA NGF receptors revealed by affinity crosslinking and immunoprecipitation. J Neurosci Res 40:557-563.
18. Hurwitz DR, Emanuel SL, Nathan MH, Sarver N, Ullrich A, Felder S, Lax I, Schlessinger J (1991): EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EOF) receptor extracellular domain. J Biol Chem 266:22035-22043.
19. Ibanez CF, Ebendal T, Persson H (1991): Chimeric molecules with multiple neurotrophic activities reveal structural elements determining the specificities of NGF and BDNF. EMBO J 10:2105-2110.
20. Ibanez C F, Ebendal T, Barbany G, Murray-Rust J, Blundell TL, Persson H (1992): Disruption of the low affinity receptorbinding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell 69:329-341.
21. Ibanez CF, Hag LL, Murray-Rust J, Persson H (1993): An extended surface of binding to Trk tyrosine kinase receptors in NGF and BDNF allows the engineering of a multifunctional panneurotrophin. EMBO J 12:2281-2293.
22. Hag LL, Lonnerberg P, Persson H, Ibanez CF (1994): Role of variable β-hairpin loop in determining biological specificities in neurotrophin family. J Biol Chem 269:19941-19946.
23. Johnson DE. Williams LT (1993): Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60:1-41.
24. Lee KF, Li E, Huber LJ, Landis SC, Sharpe AH, Chao MV, Jaenisch R (1992): Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69:737-749.
25. Lee KF, Davies AM, Jaenisch R (1994): p75-deficient embryonicdorsal root sensory neonatal sympathetic neurons display a decreased sensitivity to NGF. Development 120:1027-1033.
26. Lehmann S, Quirosa-Guillou C, Becherer U, Thal C, Zanetta J-P ( 1993): Neurite outgrowth of neurons of rat dorsal root ganglia induced by new neurotrophic substances with guanidine group. Neurosci Lett 152:57-60.
27. LeSauteur L, Wei L, Gibbs BF, Saragovi HU (1995): Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J Biol Chem 270:6564-6569.
28. Lifson JD, Hwang KM, Nara PL, Fraser B, Padgett M, Dunlop NM, Eiden LE (1988): Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. Science 241:712-716.
29. Livnah O, Stura EA, Johnson DL, Middleton SA. Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe LK, Wilson IA (1996): Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8A. Science 273:464-471.
30. Longo FM, Vu TK, Mobley WC (1990a): The in vitro biological effect of nerve growth factor is inhibited by synthetic peptides. Cell Regul 1:189-195.
31. Longo FM, Woo JE, Mobley WC (1990b): Purification of nerve growth factor. In Rush RA (ed): "Nerve Growth Factors." Chichester, UK: John Wiley and Sons, pp 3-30.
32. Longo FM, Holtzman DM, Grimes ML, Mobley WC (1993): Nerve growth factor actions in the PNS and CNS. In Loughlin SE, Fallon JH (eds): 'Neurotrophic Factors.' San Diego, CA: Academic Press, pp 209-256.
33. Longo FM, Manthorpe M, Xie YM, Varon S (1996): Neurotrophic activity of synthetic NGF peptide derivatives. Soc Neurosci Abstr 22:557.
34. Manthorpe M, Fagnani R, Skaper SD, Varon S (1986): An automated colorimetric microassay for neuronotrophic factors. Dev Brain Res 25:191-198.
35. Mattson MP, Cheng B, Smith-Swintosky VL (1993): Mechanisms of neurotrophic factor protection against calcium- and free radicalmediated excitotoxic injury: Implications for treating neurodegenerative disorders. Exp Neurol 124:89-95.
36. McDonald NQ, Lapatto R, Murray-Rust J, Gunning J, Wlodawer A, Blundell TL (1991): New protein fold revealed. by a 2.3-A resolution crystal structure of nerve growth factor. Nature 354:411-414.
37. McDonald NQ, Chao MV (1995): Structural determinants of neurotrophic action. J Biol Chem 270:19669-19672.
38. Murphy RA, Acheson A, Hodges R, Haskins J, Richards C, Reklow E, Chlumecky V, Barker PA, Alderson RF, Lindsay RM (1993): Immunological relationships of NGF, BDNF, and NT-3: Recognition and functional inhibition by antibodies to NGF. J Neurosci 13:2853-2862.
39. Nelson J, Stewart R, McGivern M, Bailie JR, Walker B, Murphy RF, Wilson DJ (1991): Synthetic murine epidermal growth factor sequence 20-31 is mitogenic and angiogenic. Carcinogenesis 12:1823-1829.
40. Olson L (1993): NGF and the treatment of Alzheimer's disease. Exp Neurol 124:5-15.
41. Papayannopoulos IA, Biemann K (1992): Fast atom bombardment and tandem mass spectrometry of synthetic peptides and byproducts. Peptide Res 5:83-90.
42. Paul JW, DaVanzo JP (1992): 1,1,3 tricyano-2amino-1-propene (Triap) stimulates choline acetyltransferase activity in vitro and in vivo. Dev Brain Res 67:113-120.
43. Pelton JT, Gulya K, Hruby JV, Duckies SP, Yamumura HI (1985): Conformationally restricted analogs of somatostatin with high μ-opiate receptor specificity. Proc Natl Acad Sci USA 82:236-239.
44. Pierschbacher MD, Ruoslahti E (1987): Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem 262:17294-17298.
45. Poduslo JF, Curran GL (1996): Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Mol Brain Res 36:280-286.
46. Presta M, Rusnati M, Urbinati C, Sommer A, Ragnotti, G (1991): Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): Identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. J Cell Physiol 149:512-524.
47. Rabizadeh S, Oh J, Zhong L.-T. Yang J, Bitler CM, Butcher LL, Bredesen DE (1993): Induction of apoptosis by the low-affinity NGF receptor. Science 261:345-348.
48. Ross GM, Dory M, Weaver DF, Riopelle RJ (1994): Conformationally constrained peptides block NGF binding to P75NGFR and TrkA and inhibit NGF-mediated neurite growth by sensory neurons in vitro. Soc Neurosci Abstr 20:678.
49. LNGFR in NT-4 signaling. EMBO J 14:1979-1990.
50. Saffran B (1992): Should intracerebroventricular nerve growth factor be used to treat Alzheimer's disease? Perspectives Biol Med 35:471-486.
51. Saragovi HU, Greene MI, Chrusciel RA, Kahn M (1992): Loops and secondary structure mimeties: Development and applications in basic science and rational drug design. Bio/Teehnoiogy 10:773-778.
52. Suter U, Angst C, Tien C-L, Drinkwater CC, Lindsay RM, Shooter EM (1992): NGF/BDNF chimeric proteins: Analysis of neurotrophin specificity by homolog-scanning mutagenesis. J Neurosci 12:306-318.
53. trkA does not abolish nerve growth factor-mediated rescue of serum-free PC12 cells. J Neurochem 66:1826-1835.
54. Thoenen H, Hughes RA, Sendtner M (1993): Trophic support of motoneurons: Physiological, pathological, and therapeutic implications. Exp Neurol 124:47-55.
55. Wells JA (1996): Hormone mimicry. Science 273:449-450.
56. Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ (1996): Small peptides as potent mimeties of the protein hormone erythropoietin. Science 273:458-463.